Paul Handreck

Title: Paul Handreck: Innovator in Pharmaceutical Formulations

Introduction

Paul Handreck is a notable inventor based in Glen Iris, Australia. He has made significant contributions to the field of pharmaceuticals, particularly in the formulation of injectable compositions for cancer treatment. With a total of six patents to his name, Handreck's work is characterized by innovative approaches to drug delivery systems.

Latest Patents

Among his latest patents, Handreck has developed a pharmaceutical formulation that combines paclitaxel and polyethoxylated castor oil. This formulation is designed to be relatively acidified to a pH of less than 8.1, preferably within a pH range of 5 to 7. Ethanol is optionally included in the formulation, which is specifically adapted for use in the body for cancer treatment. The formulation method involves mixing an acid with a carrier material, such as polyethoxylated castor oil, to create a carrier solution. After this, paclitaxel is added in a precise amount to ensure the resulting pH remains below 8.1. A variety of acidifying agents are described, with anhydrous citric acid being a preferred choice.

Career Highlights

Handreck's career is marked by his dedication to advancing pharmaceutical science. His innovative formulations have the potential to improve cancer treatment outcomes, showcasing his commitment to addressing critical health challenges.

Collaborations

Throughout his career, Handreck has collaborated with esteemed colleagues, including David Reginald Carver and Timothy R Prout. These partnerships have further enriched his research and development efforts.

Conclusion

Paul Handreck stands out as a significant figure in the realm of pharmaceutical innovations. His contributions, particularly in injectable compositions for cancer treatment, reflect his expertise and commitment to improving patient care.